In this regard, chemical compounds that target protein–protein and DNA binding interfaces within the USP1-UAF1-RAD51AP1 complex would be useful not only as a chemical biology tool, but could also be further developed into cancer therapeutics. This evidence concerns the gene RAD51AP1 and cancer.